Jun O Liu Selected Research

ZJ-101

10/2016	Insights into the structure-activity relationship of the anticancer compound ZJ-101, a derivative of marine natural product superstolide A: A role played by the lactone moiety.
1/2016	Insights into the structure-activity relationship of the anticancer compound ZJ-101, a derivative of marine natural product superstolide A: A critical role played by the conjugated trienyl lactone moiety.
1/2016	Insights into the structure-activity relationship of the anticancer compound ZJ-101: A critical role played by the cyclohexene ring.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun O Liu Research Topics

Disease

42	Neoplasms (Cancer) 01/2021 - 10/2003
10	Prostatic Neoplasms (Prostate Cancer) 10/2020 - 02/2009
6	Hypoxia (Hypoxemia) 09/2020 - 01/2004
5	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2010
5	Infections 07/2013 - 06/2007
5	Malaria 12/2009 - 08/2006
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2008
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2010
3	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2018 - 03/2010
2	Carcinogenesis 01/2021 - 06/2012
2	Leukemia 01/2021 - 02/2016
2	Inflammation (Inflammations) 10/2020 - 01/2016
2	Stomach Neoplasms (Stomach Cancer) 10/2019 - 10/2015
2	Wounds and Injuries (Trauma) 01/2019 - 09/2014
2	Carcinoma (Carcinomatosis) 10/2015 - 01/2008
2	Neoplasm Metastasis (Metastasis) 07/2014 - 03/2010
2	Lung Neoplasms (Lung Cancer) 05/2013 - 11/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2013 - 11/2011
2	Tuberculosis (Tuberculoses) 09/2012 - 12/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2011 - 01/2004
2	Medulloblastoma 10/2011 - 04/2010
2	Coinfection 12/2009 - 06/2007
1	Obesity 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Retinal Diseases 01/2021
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 10/2019
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2019
1	Reperfusion Injury 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018
1	Rheumatoid Arthritis 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Drug-Related Side Effects and Adverse Reactions 12/2016

Drug/Important Bio-Agent (IBA)

21	Pharmaceutical PreparationsIBA 01/2021 - 05/2006
7	EnzymesIBA 10/2020 - 05/2011
7	Itraconazole (Sporanox)FDA LinkGeneric 06/2020 - 04/2010
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
6	Biological ProductsIBA 10/2016 - 03/2005
4	Glucose (Dextrose)FDA LinkGeneric 09/2020 - 03/2010
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2019 - 12/2010
4	CholesterolIBA 01/2018 - 03/2010
3	triptolideIBA 01/2021 - 01/2016
3	ZJ-101IBA 10/2016 - 01/2016
3	Methionine (L-Methionine)FDA Link 07/2013 - 12/2009
2	Adenosine Triphosphate (ATP)IBA 11/2019 - 07/2009
2	Phosphotransferases (Kinase)IBA 11/2019 - 02/2016
2	clofoctolIBA 10/2019 - 10/2014
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 09/2014
2	Tacrolimus Binding Proteins (FKBP)IBA 01/2019 - 01/2019
2	LactonesIBA 10/2016 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2016 - 06/2007
2	AminopeptidasesIBA 07/2013 - 09/2012
2	Angiogenesis InhibitorsIBA 11/2011 - 01/2011
2	Cardiac GlycosidesIBA 06/2011 - 12/2008
2	Digoxin (Digitek)FDA LinkGeneric 06/2011 - 12/2008
2	Small Interfering RNA (siRNA)IBA 05/2011 - 03/2010
2	AnthracyclinesIBA 08/2010 - 02/2009
2	Daunorubicin (Cerubidine)FDA LinkGeneric 08/2010 - 02/2009
2	Mefloquine (Lariam)FDA LinkGeneric 12/2009 - 02/2009
2	Transcription Factors (Transcription Factor)IBA 10/2009 - 10/2003
2	Chloroquine (Aralen)FDA LinkGeneric 09/2006 - 08/2006
1	Crystallins (Crystallin)IBA 01/2021
1	Arsenic Trioxide (Trisenox)FDA Link 01/2021
1	AGRO 100IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Ethacrynic Acid (Etacrynic Acid)FDA Link 01/2021
1	AntigensIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	NucleolinIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	fms-Like Tyrosine Kinase 3IBA 01/2021
1	FucosyltransferasesIBA 10/2020
1	EpitopesIBA 10/2020
1	FucoseIBA 10/2020
1	Guanosine Diphosphate Fucose (GDP Fucose)IBA 10/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2020
1	Adenosine Monophosphate (AMP)IBA 11/2019
1	Viral ProteinsIBA 10/2019
1	LigandsIBA 01/2019
1	Equilibrative Nucleoside Transporter 1IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Cytochrome P-450 CYP3AIBA 12/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	Janus Kinase InhibitorsIBA 01/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018
1	SterolsIBA 01/2018
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2018
1	tofacitinibIBA 01/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2017
1	cepharanthineIBA 11/2017
1	Niemann-Pick C1 ProteinIBA 11/2017
1	Cisplatin (Platino)FDA LinkGeneric 11/2017
1	ibrutinibIBA 01/2017
1	idelalisibIBA 01/2017
1	Dasatinib (BMS 354825)FDA Link 01/2017

Therapy/Procedure

12	Therapeutics 01/2021 - 08/2006
4	Drug Therapy (Chemotherapy) 11/2017 - 02/2009
2	Immunotherapy 01/2021 - 01/2021